| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/31/2011 | US20110077294 R-(-) / s-(+)-7-[3-n substituted amino-2 hydroxypropoxy] flavones |
| 03/31/2011 | US20110077288 Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases |
| 03/31/2011 | US20110077277 Organic compounds |
| 03/31/2011 | US20110077274 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 03/31/2011 | US20110077273 New benzimidazole derivatives |
| 03/31/2011 | US20110077270 Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077262 Novel spirochromanone carboxylic acids |
| 03/31/2011 | US20110077255 Substituted xanthine derivatives |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077248 Imidazopyridine and related analogs as sirtuin modulators |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077234 Urea Glucokinase Activators |
| 03/31/2011 | US20110077232 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
| 03/31/2011 | US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 03/31/2011 | US20110077212 Therapeutic uses of sglt2 inhibitors |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077198 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 03/31/2011 | US20110077197 Novel insulin derivatives having an extremely delayed time-action profile |
| 03/31/2011 | US20110077196 Non-standard insulin analogues |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077193 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for the Treatment of Infection and Topical Condition in Mammals |
| 03/31/2011 | US20110077191 Novel inhibitors of mammalian tight junction opening |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076317 Rapid establishment and/or termination of substantial steady-state drug delivery |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076284 Novel Modulators |
| 03/31/2011 | US20110076258 Methods of modulating t cell- dependent immune responses |
| 03/31/2011 | US20110076257 Modified Nucleotide Sequence Encoding Glucagon-Like Peptide-1 (GLP-1), Nucleic Acid Construct Comprising Same for Production of Glucagon-Like Peptide-1 (GLP-1), Human Cells Comprising Said Construct and Insulin-Producing Constructs, and Method of Use Thereof |
| 03/31/2011 | US20110076254 Porous scaffolds for stem cell renewal |
| 03/31/2011 | US20110076239 Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type |
| 03/31/2011 | US20110076234 Peptides comprising an isodgr motif |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2774616A1 Composition and method for treatment of diabetes |
| 03/31/2011 | CA2774008A1 Toll-like receptor modulators and uses thereof |
| 03/31/2011 | CA2773099A1 Novel modulators |
| 03/31/2011 | CA2772188A1 Gpr 119 modulators |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2302039A1 Virus-like particles comprising HML-2 gag polypeptide |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301936A1 Spirodiamine-diarylketoxime derivative |
| 03/30/2011 | EP2301935A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301929A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301629A2 Anti-interferon-alpha antibodies |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2301550A1 Tetracycline compounds having target therapeutic activities |
| 03/30/2011 | EP2301543A1 A pharmaceutical composition for treating diabetes |
| 03/30/2011 | EP2301537A1 Zonisamide for the treatment of obesity |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301529A1 Hydroxymethylbutyrate compositions and uses thereof |
| 03/30/2011 | EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/30/2011 | EP2300442A2 Compounds and methods for modulating g protein-coupled receptors |
| 03/30/2011 | EP2300046A2 Super fast-acting insulin compositions |
| 03/30/2011 | EP2300031A2 Methods and compositions for oral administration of exenatide |
| 03/30/2011 | EP2300028A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 03/30/2011 | EP2300020A2 Nutritive compositions and methods of using same |
| 03/30/2011 | EP2300018A1 Paeoniflorin preparations and uses thereof for fat reduction |
| 03/30/2011 | EP2300007A1 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 03/30/2011 | EP2300002A1 Escalating dosing regimen for effecting weight loss and treating obesity |
| 03/30/2011 | EP1829536B1 Ameliorant for renal insufficiency |
| 03/30/2011 | EP1507515B1 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 03/30/2011 | EP1503773B1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/30/2011 | CN201775804U Composite structure of drug for treating type 2 diabetes |
| 03/30/2011 | CN1966500B Quinoxaline derivative, preparation method and uses |
| 03/30/2011 | CN1956995B Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 03/30/2011 | CN1946398B Thiadiazolidinones as gsk-3 inhibitors |
| 03/30/2011 | CN1910168B Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors |
| 03/30/2011 | CN1814040B Compound liquid capsule of Chinese caterpillar fungus and quality control method |
| 03/30/2011 | CN1496738B Fenofibrate medicine composition with high bio-availability and preparation method thereof |
| 03/30/2011 | CN101998998A Aminosugar compound and process for production thereof |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998962A Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof |
| 03/30/2011 | CN101998864A 调节t细胞依赖性免疫应答的方法 The method of regulating cell-dependent immune response t |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101998853A Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators |
| 03/30/2011 | CN101993496A Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof |
| 03/30/2011 | CN101993494A N-terminal chemical modification and application of human fibroblast growth factor-21 (hFGF-21) |
| 03/30/2011 | CN101993485A Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof |
| 03/30/2011 | CN101993438A Method for extracting mangiferin and total saponins of rhizoma anemarrhenae from rhizoma anemarrhenae |
| 03/30/2011 | CN101993403A Azetidinone compound and medical applications thereof |
| 03/30/2011 | CN101991854A Novel blood fat-lowering composition |
| 03/30/2011 | CN101991853A Statin magnesium-containing blood lipid lowering composition |
| 03/30/2011 | CN101991801A Traditional Chinese medicine for treating diabetic feet |
| 03/30/2011 | CN101991800A Traditional Chinese medicine for treating diabetic foot |
| 03/30/2011 | CN101991786A Formula of medicine for reducing blood fat and preparations thereof |
| 03/30/2011 | CN101991779A Traditional Chinese medicine for treating constipation caused by diabetes |
| 03/30/2011 | CN101991778A Traditional Chinese medicine preparation for treating diabetes |